High Insulin Requirements and Poor Metabolic Control do not Modify the Expression , Regulation and PKC Mediated Activation of the p 21 ras Pathway in PBMC from Type II Diabetic Patients

[1]  T. Pawson.  Protein Modules and Signaling Networks , 2000 .

[2]  J. Zierath,et al.  Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. , 2000, Diabetes.

[3]  M. Mostert,et al.  Insulin resistance in obese subjects and newly diagnosed NIDDM patients and derangements of pyruvate dehydrogenase in their circulating lymphocytes , 1997, International Journal of Obesity.

[4]  A. Ullrich,et al.  Tumor necrosis factor-alpha- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling. , 1996, The Journal of clinical investigation.

[5]  G. Elberg,et al.  Lactogenic hormones rapidly activate p21ras/mitogen-activated protein kinase in Nb2-11C rat lymphoma cells , 1996, Endocrine.

[6]  M. Leppert,et al.  Linkage Analysis of 19 Candidate Regions for Insulin Resistance in Familial NIDDM , 1995, Diabetes.

[7]  D. Cantrell,et al.  The regulation and function of p21ras during T-cell activation and growth. , 1995, Immunology today.

[8]  C. R. Kahn,et al.  Insulin Action, Diabetogenes, and the Cause of Type II Diabetes , 1994, Diabetes.

[9]  C. Kahn,et al.  Rad: a member of the Ras family overexpressed in muscle of type II diabetic humans. , 1993, Science.

[10]  R. Vigneri,et al.  Insulin receptor tyrosine kinase activity is reduced in monocytes from non-obese normoglycaemic insulin-resistant subjects , 1993, Diabetologia.

[11]  A. Porras,et al.  The ras signaling pathway mimics insulin action on glucose transporter translocation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Jaramillo,et al.  Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21ras activation , 1993, The Journal of experimental medicine.

[13]  R. Grand,et al.  The biochemistry of ras p21. , 1991, The Biochemical journal.

[14]  R. Medema,et al.  Insulin stimulation of gene expression mediated by p21ras activation. , 1991, The EMBO journal.

[15]  D. Alexander,et al.  Guanine nucleotide regulation of inositol phospholipid hydrolysis and CD3-antigen phosphorylation in permeabilized T lymphocytes. , 1990, The Biochemical journal.

[16]  L. J. Korn,et al.  Ras p21 as a potential mediator of insulin action in Xenopus oocytes. , 1987, Science.

[17]  L. Mandarino,et al.  Abnormal coupling of insulin receptor binding in noninsulin-dependent diabetes. , 1984, The American journal of physiology.

[18]  J. Clot,et al.  Circulating lymphocyte subpopulations in juvenile insulin-dependent diabetes , 2004, Diabetologia.

[19]  Y. Ramot,et al.  Defective activation of p21ras in peripheral blood mononuclear cells from patients with insulin dependent diabetes mellitus. , 1999, Autoimmunity.

[20]  居出 理惠.  High glucose condition desensitizes insulin action at the levels of receptor kinase , 1995 .

[21]  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. , 1979, Diabetes.